Matches in SemOpenAlex for { <https://semopenalex.org/work/W3063069714> ?p ?o ?g. }
- W3063069714 endingPage "2002791" @default.
- W3063069714 startingPage "2002791" @default.
- W3063069714 abstract "Combination therapies that target multiple pathways involved in immune rejection of transplants hold promise for patients in need of restorative surgery. Herein, a noninteracting multiphase molecular assembly approach is developed to crystallize tofacitinib, a potent JAK1/3 inhibitor, within a shear-thinning self-assembled fibrillar peptide hydrogel network. The resulting microcrystalline tofacitinib hydrogel (MTH) can be syringe-injected directly to the grafting site during surgery to locally deliver the small molecule. The rate of drug delivered from MTH is largely controlled by the dissolution of the encapsulated microcrystals. A single application of MTH, in combination with systemically delivered CTLA4-Ig, a co-stimulation inhibitor, affords significant graft survival in mice receiving heterotopic heart transplants. Locoregional studies indicate that the local delivery of tofacitinib at the graft site enabled by MTH is required for the observed enhanced graft survival." @default.
- W3063069714 created "2020-08-24" @default.
- W3063069714 creator A5003567656 @default.
- W3063069714 creator A5008397618 @default.
- W3063069714 creator A5013881770 @default.
- W3063069714 creator A5016218098 @default.
- W3063069714 creator A5020444758 @default.
- W3063069714 creator A5026518053 @default.
- W3063069714 creator A5034579880 @default.
- W3063069714 creator A5042689207 @default.
- W3063069714 creator A5045660547 @default.
- W3063069714 creator A5050212687 @default.
- W3063069714 creator A5051728520 @default.
- W3063069714 creator A5062260819 @default.
- W3063069714 creator A5074805124 @default.
- W3063069714 creator A5082962021 @default.
- W3063069714 creator A5088578489 @default.
- W3063069714 date "2020-08-18" @default.
- W3063069714 modified "2023-09-25" @default.
- W3063069714 title "Multiphase Assembly of Small Molecule Microcrystalline Peptide Hydrogel Allows Immunomodulatory Combination Therapy for Long‐Term Heart Transplant Survival" @default.
- W3063069714 cites W1495625233 @default.
- W3063069714 cites W1526832479 @default.
- W3063069714 cites W1602888306 @default.
- W3063069714 cites W1774599741 @default.
- W3063069714 cites W1801206013 @default.
- W3063069714 cites W1963416087 @default.
- W3063069714 cites W1971308765 @default.
- W3063069714 cites W1985562289 @default.
- W3063069714 cites W1999361516 @default.
- W3063069714 cites W2000581651 @default.
- W3063069714 cites W2005635080 @default.
- W3063069714 cites W2014081699 @default.
- W3063069714 cites W2017151568 @default.
- W3063069714 cites W2021800338 @default.
- W3063069714 cites W2023137485 @default.
- W3063069714 cites W2030855575 @default.
- W3063069714 cites W2035346630 @default.
- W3063069714 cites W2050207992 @default.
- W3063069714 cites W2063861785 @default.
- W3063069714 cites W2069280468 @default.
- W3063069714 cites W2075427082 @default.
- W3063069714 cites W2077389439 @default.
- W3063069714 cites W2078678444 @default.
- W3063069714 cites W2092299434 @default.
- W3063069714 cites W2113570624 @default.
- W3063069714 cites W2117926449 @default.
- W3063069714 cites W2118061894 @default.
- W3063069714 cites W2121219094 @default.
- W3063069714 cites W2122136428 @default.
- W3063069714 cites W2135694095 @default.
- W3063069714 cites W2152079015 @default.
- W3063069714 cites W2155144605 @default.
- W3063069714 cites W2155510706 @default.
- W3063069714 cites W2165457831 @default.
- W3063069714 cites W2225592990 @default.
- W3063069714 cites W2311074354 @default.
- W3063069714 cites W2322822962 @default.
- W3063069714 cites W2474214037 @default.
- W3063069714 cites W2594768604 @default.
- W3063069714 cites W2619102628 @default.
- W3063069714 cites W2696499577 @default.
- W3063069714 cites W2747301509 @default.
- W3063069714 cites W2791182757 @default.
- W3063069714 cites W2791931250 @default.
- W3063069714 cites W2887399354 @default.
- W3063069714 cites W2893152850 @default.
- W3063069714 cites W2894527492 @default.
- W3063069714 cites W2902979010 @default.
- W3063069714 cites W2949742175 @default.
- W3063069714 cites W2981131383 @default.
- W3063069714 cites W4234566972 @default.
- W3063069714 cites W2038952545 @default.
- W3063069714 doi "https://doi.org/10.1002/smll.202002791" @default.
- W3063069714 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7686956" @default.
- W3063069714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32812339" @default.
- W3063069714 hasPublicationYear "2020" @default.
- W3063069714 type Work @default.
- W3063069714 sameAs 3063069714 @default.
- W3063069714 citedByCount "13" @default.
- W3063069714 countsByYear W30630697142020 @default.
- W3063069714 countsByYear W30630697142021 @default.
- W3063069714 countsByYear W30630697142022 @default.
- W3063069714 countsByYear W30630697142023 @default.
- W3063069714 crossrefType "journal-article" @default.
- W3063069714 hasAuthorship W3063069714A5003567656 @default.
- W3063069714 hasAuthorship W3063069714A5008397618 @default.
- W3063069714 hasAuthorship W3063069714A5013881770 @default.
- W3063069714 hasAuthorship W3063069714A5016218098 @default.
- W3063069714 hasAuthorship W3063069714A5020444758 @default.
- W3063069714 hasAuthorship W3063069714A5026518053 @default.
- W3063069714 hasAuthorship W3063069714A5034579880 @default.
- W3063069714 hasAuthorship W3063069714A5042689207 @default.
- W3063069714 hasAuthorship W3063069714A5045660547 @default.
- W3063069714 hasAuthorship W3063069714A5050212687 @default.
- W3063069714 hasAuthorship W3063069714A5051728520 @default.
- W3063069714 hasAuthorship W3063069714A5062260819 @default.
- W3063069714 hasAuthorship W3063069714A5074805124 @default.
- W3063069714 hasAuthorship W3063069714A5082962021 @default.